Trulieve Stock Rally Stalls as Debt Concerns Resurface Ahead of Q1 Earnings
By Sheeba M. | April 30, 2026 Trulieve Stock Rally Stalls as Debt Concerns Resurface Ahead of Q1 Earnings TL;DR: Trulieve (TCNNF) shares slide 6% on debt refinancing concerns; earnings call May 15 could be make-or-break for stock momentum. Debt Load Looms Over Florida’s Cannabis Leader Trulieve Cannabis (TCNNF), the nation’s largest MSO by store […]
Cannabis ETF Outflows Accelerate as Investors Reassess MSO Growth Trajectory
By Sheeba M. | April 30, 2026 Cannabis ETF Outflows Accelerate as Investors Reassess MSO Growth Trajectory TL;DR: Major cannabis ETFs seeing $500M+ outflows as inflation pressures consumer spending; MSOs face margin compression despite revenue growth. Market Headwinds Impact Cannabis Funds Cannabis-focused ETFs including MSOS (AdvisorShares Pure US Cannabis) have experienced significant outflows over the […]
Cannabis-Focused ETFs See New Inflows as Institutional Interest Heats Up
By Sheeba M. | April 30, 2026 Cannabis-Focused ETFs See New Inflows as Institutional Interest Heats Up TL;DR: Rising institutional participation in cannabis ETFs signals growing mainstream acceptance—index rebalancing and new fund launches expected in H2 2026. Cannabis ETFs are experiencing a renaissance as institutional investors gain comfort with the sector’s valuation multiples and regulatory […]
Trulieve and Curaleaf Compete for Market Dominance in Q2 Retail Expansion
By Sheeba M. | April 30, 2026 Trulieve and Curaleaf Compete for Market Dominance in Q2 Retail Expansion TL;DR: Major retailers expand store counts while maintaining profitability—institutional investors watch for margin pressure and consolidation opportunities ahead. The cannabis retail landscape is heating up as Trulieve Cannabis and Curaleaf Holdings compete aggressively for market share across […]
Global Cannabis Expansion: Mexico, Germany, and Australia Racing for Market Share
By Sheeba M. | April 30, 2026 Global Cannabis Expansion: Mexico, Germany, and Australia Racing for Market Share TL;DR: Mexico legalized recreational cannabis. Germany is fast-tracking distribution. Australia just approved medical imports. U.S. MSOs with international footprints—especially GTBIF—are positioned for 3x revenue growth by 2028. If you’re tracking cannabis stocks and only looking at U.S. […]
Federal Rescheduling Timeline: What Schedule III Means for Investors
By Sheeba M. | April 30, 2026 Federal Rescheduling Timeline: What Schedule III Means for Investors TL;DR: If cannabis moves to Schedule III in H2 2026, institutional capital unlocks instantly. Banks enter, valuations spike 35-50%, and MSOs like CURLF recapture $12B in trapped equity value. The betting markets are shifting. Congressional momentum on cannabis rescheduling […]
CBD Market Expansion: Why 2026 Is Different From Previous Hype Cycles
By Sheeba M. | April 29, 2026 CBD Market Expansion: Why 2026 Is Different From Previous Hype Cycles TL;DR: FDA guidance on CBD products (issued Q1 2026) is clearing regulatory fog. CPG brands entering the space with legitimacy signal real market traction—not hype. CBD revenues could triple by 2028 from today’s $4.8B base. Remember the […]
Cannabis Retail Sales Surge: Q1 2026 Recovery Signals Market Stabilization
By Sheeba M. | April 29, 2026 Cannabis Retail Sales Surge: Q1 2026 Recovery Signals Market Stabilization TL;DR: Q1 2026 retail cannabis sales reached $6.2B, marking the first sustained recovery since mid-2024. Multi-state operators with strong MSO portfolios are poised for accelerated growth as consumer demand normalizes. After two years of margin compression and consolidation, […]
Q2 Cannabis Earnings: 5 Plays to Watch Before May 30
By Sheeba M. | April 29, 2026 Q2 Cannabis Earnings: 5 Plays to Watch Before May 30 TL;DR: CURLF, TLRY, and CRON report earnings in the next 30 days—watch for margin compression and guidance cuts as recreational demand normalizes post-legalization euphoria. Cannabis operator earnings are no longer binary bets. The sector has matured. May’s earnings […]
Cannabis ETFs vs Individual Stocks: Which Strategy Wins?
By Sheeba M. | April 29, 2026 Cannabis ETFs vs Individual Stocks: Which Strategy Wins? TL;DR: As cannabis legalization spreads, institutional investors are choosing diversified ETFs over individual picks—but savvy traders can still profit from emerging plays like CURLF and TLRY. The cannabis investment landscape has shifted dramatically. While 2020-2021 saw individual stock darlings like […]